HIV infection is characterized by a persistent immune activation associated to a compromised gut barrier immunity and alterations in the profile of the fecal flora linked with the progression of inflammatory symptoms. The effects of high concentration multistrain probiotic (Vivomixx®, Viale del Policlinico 155, Rome, Italy in EU; Visbiome®, Dupont, Madison, Wisconsin in USA) on several aspects of intestinal immunity in ART-experienced HIV-1 patients was evaluated.
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients / D'Ettorre, G., Rossi, G., Scagnolari, C., Andreotti, M., Giustini, N., Serafino, S., Schietroma, I., Corano Scheri, G., Fard, S.N., Trinchieri, V., Mastromarino, P., Selvaggi, C., Scarpona, S., Fanello, G., Fiocca, F., Ceccarelli, G., Antonelli, G., Brenchley, J.M., Vullo, V.. - In: IMMUNITY, INFLAMMATION AND DISEASE. - ISSN 2050-4527. - ELETTRONICO. - 5:3(2017), pp. 244-260. [10.1002/iid3.160]
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients
D'Ettorre, Gabriella;Scagnolari, Carolina;Andreotti, Mauro;Giustini, Noemi;Serafino, Sara;Corano Scheri, Giuseppe;Fard, Saeid Najafi;Trinchieri, Vito;Mastromarino, Paola;Selvaggi, Carla;Fanello, Gianfranco;Fiocca, Fausto;Ceccarelli, Giancarlo;Antonelli, Guido;Vullo, Vincenzo
2017
Abstract
HIV infection is characterized by a persistent immune activation associated to a compromised gut barrier immunity and alterations in the profile of the fecal flora linked with the progression of inflammatory symptoms. The effects of high concentration multistrain probiotic (Vivomixx®, Viale del Policlinico 155, Rome, Italy in EU; Visbiome®, Dupont, Madison, Wisconsin in USA) on several aspects of intestinal immunity in ART-experienced HIV-1 patients was evaluated.| File | Dimensione | Formato | |
|---|---|---|---|
|
D'Ettorre_Probiotic_2017.pdf
accesso aperto
Note: articolo principale
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
2.25 MB
Formato
Adobe PDF
|
2.25 MB | Adobe PDF | |
|
D'Ettorre_Probiotic-supplementation_2017.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
2.27 MB
Formato
Adobe PDF
|
2.27 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
